These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31415769)

  • 21. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
    Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
    Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin D receptor alleviates lipid peroxidation in diabetic nephropathy by regulating ACLY/Nrf2/Keap1 pathway.
    Zhou Y; Liao Q; Li D; Chen L; Zhang H; Yi B
    FASEB J; 2024 Sep; 38(18):e70060. PubMed ID: 39302807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.
    Chen G; Wang P; Zhao G; Xu G; Gruzdev A; Zeldin DC; Wang DW
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):63-71. PubMed ID: 21742052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC3 promotes the nuclear translocation of the vitamin D receptor and decreases fibrogenic gene expression in proximal renal tubules.
    Li A; Zhang H; Han H; Zhang W; Yang S; Huang Z; Tan J; Yi B
    Metabolism; 2019 Sep; 98():95-103. PubMed ID: 31226352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
    Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D receptor signaling in podocytes protects against diabetic nephropathy.
    Wang Y; Deb DK; Zhang Z; Sun T; Liu W; Yoon D; Kong J; Chen Y; Chang A; Li YC
    J Am Soc Nephrol; 2012 Dec; 23(12):1977-86. PubMed ID: 23123403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D and proteinuria: a critical review of molecular bases and clinical experience.
    Pérez-Gómez MV; Ortiz-Arduán A; Lorenzo-Sellares V
    Nefrologia; 2013; 33(5):716-26. PubMed ID: 24089164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney.
    Ma J; Qu W; Scarborough PE; Tomer KB; Moomaw CR; Maronpot R; Davis LS; Breyer MD; Zeldin DC
    J Biol Chem; 1999 Jun; 274(25):17777-88. PubMed ID: 10364221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.
    Chen G; Xu R; Wang Y; Wang P; Zhao G; Xu X; Gruzdev A; Zeldin DC; Wang DW
    Am J Physiol Endocrinol Metab; 2012 Sep; 303(5):E563-75. PubMed ID: 22739108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.
    Tan X; Wen X; Liu Y
    J Am Soc Nephrol; 2008 Sep; 19(9):1741-52. PubMed ID: 18525004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1 activator ameliorates the renal tubular injury induced by hyperglycemia in vivo and in vitro via inhibiting apoptosis.
    Wang XL; Wu LY; Zhao L; Sun LN; Liu HY; Liu G; Guan GJ
    Biomed Pharmacother; 2016 Oct; 83():41-50. PubMed ID: 27470548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
    Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
    Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pigment epithelium-derived factor, a noninhibitory serine protease inhibitor, is renoprotective by inhibiting the Wnt pathway.
    He X; Cheng R; Park K; Benyajati S; Moiseyev G; Sun C; Olson LE; Yang Y; Eby BK; Lau K; Ma JX
    Kidney Int; 2017 Mar; 91(3):642-657. PubMed ID: 27914705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verapamil ameliorates proximal tubular epithelial cells apoptosis and fibrosis in diabetic kidney.
    Song Y; Guo F; Zhao Y; Zhao L; Fan X; Zhang Y; Liu Y; Qin G
    Eur J Pharmacol; 2021 Nov; 911():174552. PubMed ID: 34627808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
    Ding S; Qiu H; Huang J; Chen R; Zhang J; Huang B; Zou X; Cheng O; Jiang Q
    Chem Biol Interact; 2019 Jul; 307():116-124. PubMed ID: 31063766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy.
    Wang B; Qian JY; Tang TT; Lin LL; Yu N; Guo HL; Ni WJ; Lv LL; Wen Y; Li ZL; Wu M; Cao JY; Liu BC
    Diabetes; 2021 Nov; 70(11):2639-2651. PubMed ID: 34376476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRAF3 Modulation: Novel Mechanism for the Anti-inflammatory Effects of the Vitamin D Receptor Agonist Paricalcitol in Renal Disease.
    Rayego-Mateos S; Morgado-Pascual JL; Valdivielso JM; Sanz AB; Bosch-Panadero E; Rodrigues-Díez RR; Egido J; Ortiz A; González-Parra E; Ruiz-Ortega M
    J Am Soc Nephrol; 2020 Sep; 31(9):2026-2042. PubMed ID: 32631974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D receptor-modulated Hsp70/AT1 expression may protect the kidneys of SHRs at the structural and functional levels.
    García IM; Altamirano L; Mazzei L; Fornés M; Cuello-Carrión FD; Ferder L; Manucha W
    Cell Stress Chaperones; 2014 Jul; 19(4):479-91. PubMed ID: 24222043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD; Zella JB; Prahl JM; DeLuca HF
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells.
    Ahad A; Ahsan H; Mujeeb M; Siddiqui WA
    Chem Biol Interact; 2015 Oct; 240():292-303. PubMed ID: 26341651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.